New Drug Trial Could Halt Alzheimer’s Memory Loss

A new nationwide clinical trial is currently recruiting people with Alzheimer’s disease to see if a new drug can halt or slow down memory loss and other symptoms.

The trial, called “T2 Protect AD,” involves 48 weeks of treatment and monitoring. Subjects will receive either a placebo or a drug called troriluzole, which has been shown to slow down the rate at which brain cells die off, according to WGME — and if it’s successful, the trial could chart a new course for dementia treatment..."